Investing Profile

John Hamer

VCInvestor
Managing Director at Financial Services, Financial Technology, and Business Services
dcvc.com/bio/core/dr-john-ham...San Francisco, California
Photo of John Hamer, Managing Director at Financial Services, Financial Technology, and Business Services
Your Intro Paths to John Hamer

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks John is a member of
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
University of California, Davis Network
111 CONNECTIONS
US Davis California Raptor Center Network
24 CONNECTIONS
Monsanto Company Network
16 CONNECTIONS

Find John Hamer on

cb
Current Investing Position
Financial Services, Financial Technology, and Business Services Managing Director
Investment Range
$5.0M - $25.0M
Sweet Spot
$15.0M
Investments On Record
19

John Hamer is on these Sector & Stage Rankings

John Hamer's Investments On Record (12)

CompanyStageDateRound SizeTotal Raised
Sidewinder Therapeutics
Series BApr 2026$140M
$140M
Co-investors: Michal Silverberg (Novartis Venture Fund), Daniel Estes (Frazier Life Sciences)
Solu Therapeutics
Series AApr 2025$41M
SeedAug 2023$31M
$72M
Co-investors: Christoph Westphal (Self-employed)
Totus Medicines
Series BDec 2023$66M
$110M
Co-investors: Jason Pontin (DCVC (Data Collective)), Kiersten Stead (DCVC Bio), Sarah Cone (Prequel Strategies)
CH4 Global
Series BAug 2023$29M
Series AOct 2021$13M
$42M
Co-investors: Zachary Bogue (DCVC (Data Collective))
BioPhero
Series AMar 2021$17M
$21M
Co-investors: Michael Lee (Syngenta Group Ventures), Shubhang Shankar (Syngenta Group Ventures)
Covercress
Series UnknownMar 2017$2M
Series AMay 2015$3M
$5M
Co-investors: Rick Holton, Jr. (Cultivation Capital)
Bioceres S.A.
Series UnknownApr 2016
Pivot Bio
Series AMar 2016$16M
SeedOct 2014$750K
$620M
Co-investors: Carmichael Roberts (Breakthrough Energy Ventures), Mark Cupta (Breakthrough Energy Ventures), Matt Ocko (DCVC (Data Collective)), Alan Cohen (DCVC (Data Collective)), Kris Kemeny (Tekfen Ventures), Jenny Rooke (Genoa Ventures)

John Hamer's Experience

Visiting Scientist DuPontPresent
Editor-In-Chief, Fungal Genetics and Biology Financial Services, Financial Technology, and Business ServicesPresent
Managing Director Financial Services, Financial Technology, and Business ServicesPresent
Chairperson Chromatin, Inc.Present
Invited Lecturer US Davis California Raptor CenterPresent
Invited Lecturer UC Davis Graduate School of ManagementPresent
Monsanto Growth Ventures Monsanto CompanyPresent
Board of Trustee Alliance of Bioversity International and CIATPresent
CSO, CEO, VP Business Development Paradigm GeneticsPresent
CEO Arete TherapeuticsPresent

John Hamer's Education

University of Windsor B.Sc. Biology
University of Windsor M.Sc. Biological Sciences
University of California, Davis Ph.D Microbiology

Investors who invest with John Hamer

Sign in with Google →

Scouts & Angels Affiliated With John Hamer

Sign in with Google →